Detalhe da pesquisa
1.
Geographic Variation and Environmental Predictors of Nontuberculous Mycobacteria in Laboratory Surveillance, Virginia, USA, 2021-20231.
Emerg Infect Dis
; 30(3): 548-554, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38407146
2.
Development and Validation of a UPLC-MS/MS Method for Therapeutic Drug Monitoring, Pharmacokinetic and Stability Studies of First-Line Antituberculosis Drugs in Urine.
Molecules
; 29(2)2024 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38257250
3.
Pharmacokinetic-Pharmacodynamic Determinants of Clinical Outcomes for Rifampin-Resistant Tuberculosis: A Multisite Prospective Cohort Study.
Clin Infect Dis
; 76(3): 497-505, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731948
4.
Nouveau short-course therapy and morphism mapping for clinical pulmonary Mycobacterium kansasii.
Antimicrob Agents Chemother
; 95(5)2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33558291
5.
Simplified urine-based method to detect rifampin underexposure in adults with tuberculosis: a prospective diagnostic accuracy study.
Antimicrob Agents Chemother
; 67(11): e0093223, 2023 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37877727
6.
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis.
Eur Respir J
; 61(3)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36328357
7.
Omadacycline Pharmacokinetics/Pharmacodynamics in the Hollow Fiber System Model and Potential Combination Regimen for Short Course Treatment of Mycobacterium kansasii Pulmonary Disease.
Antimicrob Agents Chemother
; 66(9): e0068722, 2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35976006
8.
Rifampin Pharmacokinetics/Pharmacodynamics in the Hollow-Fiber Model of Mycobacterium kansasii Infection.
Antimicrob Agents Chemother
; 66(4): e0232021, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35315686
9.
Impact of early diagnosis of impaired glucose regulation in tuberculosis: Comparison of clinical outcomes in people with tuberculosis in Tanzania.
Trop Med Int Health
; 27(9): 815-822, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36053910
10.
Therapeutic Drug Monitoring of Anti-infective Drugs: Implementation Strategies for 3 Different Scenarios.
Ther Drug Monit
; 44(1): 3-10, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34686647
11.
Clinical-demographic markers for improving diabetes mellitus diagnosis in people with tuberculosis in Tanzania.
BMC Infect Dis
; 22(1): 260, 2022 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35296241
12.
Mycobactericidal Effects of Different Regimens Measured by Molecular Bacterial Load Assay among People Treated for Multidrug-Resistant Tuberculosis in Tanzania.
J Clin Microbiol
; 59(4)2021 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33536294
13.
A mobile microvolume UV/visible light spectrophotometer for the measurement of levofloxacin in saliva.
J Antimicrob Chemother
; 76(2): 423-429, 2021 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33089322
14.
Levofloxacin pharmacokinetics in saliva as measured by a mobile microvolume UV spectrophotometer among people treated for rifampicin-resistant TB in Tanzania.
J Antimicrob Chemother
; 76(6): 1547-1552, 2021 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33675664
15.
TB or not TB? Definitive determination of species within the Mycobacterium tuberculosis complex in unprocessed sputum from adults with presumed multidrug-resistant tuberculosis.
Trop Med Int Health
; 26(9): 1057-1067, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34107112
16.
Clofazimine for treatment of multidrug-resistant non-tuberculous mycobacteria.
Pulm Pharmacol Ther
; 70: 102058, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34293446
17.
Adenosine deaminase negative pleural tuberculosis: a case report.
BMC Infect Dis
; 21(1): 575, 2021 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34130662
18.
Integrating Pharmacokinetics and Pharmacodynamics in Operational Research to End Tuberculosis.
Clin Infect Dis
; 70(8): 1774-1780, 2020 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31560376
19.
Comparison of a Novel Regimen of Rifapentine, Tedizolid, and Minocycline with Standard Regimens for Treatment of Pulmonary Mycobacterium kansasii.
Antimicrob Agents Chemother
; 64(10)2020 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32690646
20.
Ethionamide Population Pharmacokinetic Model and Target Attainment in Multidrug-Resistant Tuberculosis.
Antimicrob Agents Chemother
; 64(9)2020 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32631828